IP Library Granted Patent US 11,674,961
Granted Patent B2
US 11,674,961 · App. 16/600,295 · Granted Jun 13, 2023

Extraction reagent for use in an assay for detection of group A

Inventors: Peter Yan-Guo Ren (San Diego, CA); Stewart Hoelscher (San Diego, CA); Cristian Alberto (Chula Vista, CA); Stephanie Pinedo (San Diego, CA); Jason McClure (San Diego, CA); Hyunjin Kim (Beverly, MA)
Assignee: Quidel Corporation
G01N33/56944G01N33/532G01N2400/10G01N2469/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,674,961
App. No.
16/600,295
Granted
Jun 13, 2023
Kind
B2
Abstract

An enzymatic extraction agent, as well as methods, compositions and kits for detecting Group A Streptococcus in a biological sample, which involve the enzymatic agent, are described.

Claims (34)

1. An enzymatic extraction agent comprising a recombinant multimeric PlyC holoenzyme consisting of PlyCA and PlyCB gene products and a labeled antibody that specifically binds to a Strep A antigen.

2. The enzymatic extraction agent of claim 1 , wherein the antibody is coupled to microbeads, gold sol, or carbon microparticles.

3. A device for detecting the presence of Group A Streptococcus in a test sample, the device comprising:

a matrix having (i) a sample receiving zone for receiving a test sample containing or suspected of containing a Group A Streptococcus -specific antigen, wherein the test sample comprises is the biological sample and an enzymatic extraction agent comprising a recombinant multimeric PlyC holoenzyme consisting of PlyCA and PlyCB gene products and a labeled antibody that specifically binds to the Group A Streptococcus -specific antigen and (ii) a capture zone having means for specifically binding a labeled Group A Streptococcus -specific antigen thereon, wherein the sample receiving zone and the capture zone are arranged on the matrix in a liquid flow path.

4. The device of claim 3 , wherein the sample receiving zone comprises N-acetyl-D-glucosamine (NAG).

5. The device of claim 3 , wherein the antibody is a polyclonal, monoclonal, or recombinant chimeric antibody coupled to fluorescent microbeads.

6. The device of claim 3 , wherein the antibody is coupled to europium chelate-impregnated microbeads.

7. The device of claim 3 , wherein the means for specifically binding the labeled Group A Streptococcus -specific antigen is a capture antibody.

8. The device of claim 7 , wherein the capture antibody is a polyclonal, monoclonal, or recombinant chimeric antibody.

9. A kit comprising:

a device comprising a matrix having (i) a sample receiving zone for receiving a test sample containing or suspected of containing a Group A Streptococcus -specific antigen and (ii) a capture zone having means for specifically binding a labeled Group A Streptococcus -specific antigen thereon, wherein the sample receiving zone and the capture zone are arranged on the matrix in a liquid flow path; and

a container comprising the enzymatic extraction agent of claim 1 .

10. The kit of claim 9 , wherein the antibody is coupled to europium chelate-impregnated microbeads.

11. The kit of claim 9 , wherein at least one of the enzymatic extraction agent or the sample receiving zone comprise N-acetyl-D-glucosamine (NAG).

12. The kit of claim 11 , wherein the NAG is deposited on the sample receiving zone.

13. A kit comprising:

a device comprising a matrix having (i) a sample receiving zone for receiving a test sample containing or suspected of containing a Group A Streptococcus -specific antigen, wherein the test sample comprises a biological sample and the enzymatic extraction agent of claim 1 and (ii) a capture zone having means for specifically binding a labeled Group A Streptococcus -specific antigen thereon, wherein the sample receiving zone and the capture zone are arranged on the matrix in a liquid flow path;

a container comprising the enzymatic extraction agent of claim 1 ;

an instrument for collecting the biological sample; and

instructions for use.

14. The kit of claim 13 , wherein the instrument is a swab.

15. The kit of claim 13 , wherein the instructions do not caution to not touch tongue, sides or top of mouth with the instrument when collecting a sample.

16. The enzymatic extraction agent of claim 2 , wherein the microbeads are fluorescent microbeads, europium chelate-impregnated microbeads, colored microbeads, or magnetic microbeads.

17. The enzymatic extraction agent of claim 1 , wherein the extraction agent is in the form of a liquid, lyophilized or dried composition.

18. The enzymatic extraction agent of claim 17 , wherein the extraction agent is in the form of a liquid and the recombinant PlyC holoenzyme is present at a concentration from 0.1 μg/mL to 80 μg/mL.

19. The kit of claim 13 , wherein the enzymatic extraction agent is in the form of a liquid and the recombinant PlyC holoenzyme is present at a concentration from 0.1 μg/mL to 80 μg/mL.

20. The enzymatic extraction agent of 1 , wherein the recombinant multimeric PlyC holoenzyme consists of a single PlyCA protein bound to the PlyCB octamer.

21. The device of claim 3 , wherein the biological sample is collected on a swab.

22. The device of claim 3 , wherein the biological sample is a liquid sample.

23. The device of claim 22 , wherein the liquid sample is a body fluid.

24. The device of claim 23 , wherein the body fluid is urine, saliva, sputum, mucus, plasma, serum, amniotic fluid, semen, vaginal secretion, tear, spinal fluid, or body washing.

25. The device of claim 3 , wherein the biological sample is a solid or semi-solid sample.

26. The device of claim 25 , wherein the solid or the semi-solid sample is feces, biopsy specimen, or skin.

27. The device of claim 21 , wherein the sample is eluted from the swab into a transfer medium.

Assignments (5)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2021
From: REN, PETER YAN-GUO; HOELSCHER, STEWART; ALBERTO, CRISTIAN; PINEDO, STEPHANIE; MCCLURE, JASON; KIM, HYUNJIN
To: QUIDEL CORPORATION
Reel/Frame 055497/0541 →